Decreased carboxylesterases expression and hydrolytic activity in type 2 diabetic mice through Akt/mTOR/HIF-1α/Stra13 pathway

References

• American Diabetes Association. (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care 33:S62–9
   PubMed Web of Science ®Google Scholar
• Bhawal UK, Ito Y, Tanimoto K, et al. (2012). IL-1beta-mediated up-regulation of DEC1 in human gingiva cells via the Akt pathway. J Cell Biochem 113:3246–53
   PubMed Web of Science ®Google Scholar
• Boudjelal M, Taneja R, Matsubara S, et al. (1997). Overexpression of Stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of P19 cells. Genes Dev 11:2052–65
   PubMed Web of Science ®Google Scholar
• Cavazzoni A, Bonelli MA, Fumarola C, et al. (2012). Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones. Cancer Lett 323:77–87
   PubMed Web of Science ®Google Scholar
• Cheatham B, Kahn CR. (1995). Insulin action and the insulin signaling network. Endocr Rev 16:117–42
   PubMed Web of Science ®Google Scholar
• Chen R, Kim O, Yang J, et al. (2001). Regulation of Akt/PKB activation by tyrosine phosphorylation. J Biol Chem 276:31858–62
   PubMedGoogle Scholar
• Chou CH, Lai SL, Chen CN, et al. (2013). IL-6 regulates Mcl-1L expression through the JAK/PI3K/Akt/CREB signaling pathway in hepatocytes: implication of an anti-apoptotic role during liver regeneration. PLoS One 8:e66268
   PubMed Web of Science ®Google Scholar
• Dedoussis GV, Kaliora AC, Panagiotakos DB. (2007). Genes, diet and type 2 diabetes mellitus: a review. Rev Diabet Stud 4:13–24
   PubMedGoogle Scholar
• DeFuria J, Belkina AC, Jagannathan-Bogdan M, et al. (2013). B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci USA 110:5133–8
   PubMed Web of Science ®Google Scholar
• Diabetes Atlas. (2013). Available from: http://www.idf.org/diabetesatlas/5e/Update2012 [last accessed 2013 9]
   Google Scholar
• Dostalek M, Court MH, Yan B, et al. (2011). Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus. Br J Pharmacol 163:937–47
   PubMed Web of Science ®Google Scholar
• Dostalek M, Sam WJ, Paryani KR, et al. (2012). Diabetes mellitus reduces the clearance of atorvastatin lactone: results of a population pharmacokinetic analysis in renal transplant recipients and in vitro studies using human liver microsomes. Clin Pharmacokinet 51:591–606
   PubMed Web of Science ®Google Scholar
• Downward J. (1998). Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262–7
   PubMed Web of Science ®Google Scholar
• Fang J, Ding M, Yang L, et al. (2007). PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal 19:2487–97
   PubMed Web of Science ®Google Scholar
• Feige E, Yokoyama S, Levy C, et al. (2011). Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF. Proc Natl Acad Sci USA 108:E924–33
   PubMed Web of Science ®Google Scholar
• Feng XM, Xiong J, Qin H, et al. (2012). Fluoxetine induces hepatic lipid accumulation via both promotion of the SREBP1c-related lipogenesis and reduction of lipolysis in primary mouse hepatocytes. CNS Neurosci Ther 18:974–80
   PubMed Web of Science ®Google Scholar
• Fujimoto K, Shen M, Noshiro M, et al. (2001). Molecular cloning and characterization of DEC2, a new member of basic helix-loop-helix proteins. Biochem Biophys Res Commun 280:164–71
   PubMed Web of Science ®Google Scholar
• Gross V, Treher E, Haag K, et al. (1993). Angiotensin-converting enzyme (ACE)-inhibition in cirrhosis. Pharmacokinetics and dynamics of the ACE-inhibitor cilazapril (Ro 31-2848). J Hepatol 17:40–7
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Shargill NS, Spiegelman BM. (1993). Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91
   PubMed Web of Science ®Google Scholar
• Hu FB, Meigs JB, Li TY, et al. (2004). Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53:693–700
   PubMed Web of Science ®Google Scholar
• Iizuka K, Horikawa Y. (2008). Regulation of lipogenesis via BHLHB2/DEC1 and ChREBP feedback looping. Biochem Biophys Res Commun 374:95–100
   PubMed Web of Science ®Google Scholar
• Isacson D, Stalhammar J. (1987). Prescription drug use among diabetics – a population study. J Chronic Dis 40:651–60
   PubMedGoogle Scholar
• Ivanova AV, Ivanov SV, Zhang X, et al. (2004). STRA13 interacts with STAT3 and modulates transcription of STAT3-dependent targets. J Mol Biol 340:641–53
   PubMed Web of Science ®Google Scholar
• Li GS, Liu XH, Zhu H, et al. (2011). Berberine-improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver x receptors, and peroxisome proliferator-activated receptors transcriptional programs in diabetic hamsters. Biol Pharm Bull 34:644–54
   PubMed Web of Science ®Google Scholar
• Li W, Wang J, Chen QD, et al. (2013). Insulin promotes glucose consumption via regulation of miR-99a/mTOR/PKM2 pathway. PLoS One 8:e64924
   PubMed Web of Science ®Google Scholar
• Liao L, Yang M, Qiu LL, et al. (2010). Appropriate insulin initiation dosage for insulin-naive type 2 diabetes outpatients receiving insulin monotherapy or in combination with metformin and/or pioglitazone. Chin Med J (Engl) 123:3684–8
   PubMed Web of Science ®Google Scholar
• Luo J, Quan J, Tsai J, et al. (1998). Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metabolism 47:663–8
   PubMed Web of Science ®Google Scholar
• Miyazaki K, Kawamoto T, Tanimoto K, et al. (2002). Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J Biol Chem 277:47014–21
   PubMed Web of Science ®Google Scholar
• Molnar M, Wittmann I, Nagy J. (2000). Prevalence, course and risk factors of diabetic nephropathy in type-2 diabetes mellitus. Med Sci Monit 6:929–36
   PubMedGoogle Scholar
• Quiroga AD, Lehner R. (2011). Role of endoplasmic reticulum neutral lipid hydrolases. Trends Endocrinol Metab 22:218–25
   PubMed Web of Science ®Google Scholar
• Rome S, Meugnier E, Lecomte V, et al. (2009). Microarray analysis of genes with impaired insulin regulation in the skeletal muscle of type 2 diabetic patients indicates the involvement of basic helix-loop-helix domain-containing, class B, 2 protein (BHLHB2). Diabetologia 52:1899–912
   PubMed Web of Science ®Google Scholar
• Sabatini DM. (2006). mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 6:729–34
   PubMed Web of Science ®Google Scholar
• Sanghani SP, Sanghani PC, Schiel MA, et al. (2009). Human carboxylesterases: an update on CES1, CES2 and CES3. Protein Pept Lett 16:1207–14
   PubMed Web of Science ®Google Scholar
• Satoh T, Hosokawa M. (2006). Structure, function and regulation of carboxylesterases. Chem Biol Interact 162:195–211
   PubMed Web of Science ®Google Scholar
• Severgnini M, Sherman J, Sehgal A, et al. (2012). A rapid two-step method for isolation of functional primary mouse hepatocytes: cell characterization and asialoglycoprotein receptor based assay development. Cytotechnology 64:187–95
   PubMed Web of Science ®Google Scholar
• Shi D, Yang J, Yang D, et al. (2006). Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel. J Pharmacol Exp Ther 319:1477–84
   PubMed Web of Science ®Google Scholar
• Singh R, Shaw J, Zimmet P. (2004). Epidemiology of childhood type 2 diabetes in the developing world. Pediatr Diabetes 5:154–68
   PubMed Web of Science ®Google Scholar
• Staab A, Loffler J, Said HM, et al. (2007). Modulation of glucose metabolism inhibits hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha). Strahlenther Onkol 183:366–73
   PubMed Web of Science ®Google Scholar
• Tang M, Mukundan M, Yang J, et al. (2006). Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol. J Pharmacol Exp Ther 319:1467–76
   PubMed Web of Science ®Google Scholar
• Teng BS, Wang CD, Yang HJ, et al. (2011). A protein tyrosine phosphatase 1B activity inhibitor from the fruiting bodies of Ganoderma lucidum (Fr.) Karst and its hypoglycemic potency on streptozotocin-induced type 2 diabetic mice. J Agric Food Chem 59:6492–500
   PubMed Web of Science ®Google Scholar
• Thiollet M, Funck-Brentano C, Grange JD, et al. (1992). The pharmacokinetics of perindopril in patients with liver cirrhosis. Br J Clin Pharmacol 33:326–8
   PubMed Web of Science ®Google Scholar
• Thomsen R, Rasmussen HB, Linnet K. (2014). In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors. Drug Metab Dispos 42:126–33
   PubMed Web of Science ®Google Scholar
• Ueno M, Carvalheira JB, Tambascia RC, et al. (2005). Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway. Diabetologia 48:506–18
   PubMed Web of Science ®Google Scholar
• Vordermark D, Kraft P, Katzer A, et al. (2005). Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha). Cancer Lett 230:122–33
   PubMed Web of Science ®Google Scholar
• Wandell PE, Gafvels C. (2002). Drug prescription in men and women with type-2 diabetes in Stockholm in 1995 and 2001: change over time. Eur J Clin Pharmacol 58:547–53
   PubMed Web of Science ®Google Scholar
• Wang GL, Jiang BH, Rue EA, et al. (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510–14
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hotamisligil GS. (2005). Inflammation, stress, and diabetes. J Clin Invest 115:1111–19
   PubMed Web of Science ®Google Scholar
• Wu MH, Yan B, Humerickhouse R, et al. (2002). Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells. Clin Cancer Res 8:2696–700
   PubMed Web of Science ®Google Scholar
• Xiao D, Chen YT, Yang D, et al. (2012). Age-related inducibility of carboxylesterases by the antiepileptic agent phenobarbital and implications in drug metabolism and lipid accumulation. Biochem Pharmacol 84:232–9
   PubMed Web of Science ®Google Scholar
• Xiong J, Shang W, Wu L, et al. (2014). Glucose dominates the regulation of carboxylesterases induced by lipopolysaccharide or interleukin-6 in primary mouse hepatocytes. Life Sci 112:41–8
   PubMed Web of Science ®Google Scholar
• Yamada K, Kawata H, Shou Z, et al. (2003). Insulin induces the expression of the SHARP-2/Stra13/DEC1 gene via a phosphoinositide 3-kinase pathway. J Biol Chem 278:30719–24
   PubMed Web of Science ®Google Scholar
• Yang J, Shi D, Yang D, et al. (2007). Interleukin-6 alters the cellular responsiveness to clopidogrel, irinotecan, and oseltamivir by suppressing the expression of carboxylesterases HCE1 and HCE2. Mol Pharmacol 72:686–94
   PubMed Web of Science ®Google Scholar
• Yenush L, White MF. (1997). The IRS-signalling system during insulin and cytokine action. Bioessays 19:491–500
   PubMed Web of Science ®Google Scholar
• Yu J, Li J, Zhang S, et al. (2012). IGF-1 induces hypoxia-inducible factor 1alpha-mediated GLUT3 expression through PI3K/Akt/mTOR dependent pathways in PC12 cells. Brain Res 1430:18–24
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang S, Zhou S, et al. (2014). Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway. J Mol Cell Cardiol 77:42–52
   PubMed Web of Science ®Google Scholar